Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice
Open Access
- 1 August 1981
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 44 (8) , 723-724
- https://doi.org/10.1136/jnnp.44.8.723
Abstract
Thiamphenicol, rifampicin, amantadine, cytosine arabinoside and isoprinosine were administered to mice which were inoculated with brain tissue containing Creutzfeldt-Jakob disease (CJD). All the mice developed disease within 3 to 6 months after inoculation. As there was no significant shift in incubation periods among animal groups of each drug administration and non-administration, these compounds had no effect in controlling experimental CJD.Keywords
This publication has 7 references indexed in Scilit:
- Experimental transmission of human subacute spongiform encephalopathy to small rodentsActa Neuropathologica, 1981
- Properties of the transmissible agent derived from chronic spongiform encephalopathyAnnals of Neurology, 1980
- Experimental transmission of human subacute spongiform encephalopathy to small rodentsActa Neuropathologica, 1980
- TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE TO GUINEAPIGSThe Lancet, 1979
- Short report: Creutzfeldt-Jakob disease treated with amantadineJournal of Neurology, Neurosurgery & Psychiatry, 1979
- Creutzfeldt-Jakob disease treated with amantidine: A report of two casesJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the ChimpanzeeScience, 1968